Altoida, Inc.
PrivateLast Round
Series A
Mar 30, 2022
Total Funding Raised
$28.33M
Company Overview
Altoida, Inc. is a healthcare technology company that provides a precision neurology platform using AI and augmented reality to assess cognitive function and aid in the early detection of neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Healthcare Analytics, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altoida, Inc. Comparables
Compare Altoida, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cumulus Neuroscience | 86% | |
| NeuraLight | 85% | |
| Ad Scientiam | 84% |
Altoida, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 30, 2022 | ||||
| Grant | Sep 9, 2021 | ||||
| Series A | Jul 12, 2021 | ||||
| Series A Extension | May 4, 2020 | ||||
| Series A | May 31, 2019 | ||||
Seed | Dec 30, 2016 |
Key People
Founding team and executive leadership
Altoida, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grey Sky Venture Partners | Series A |
| M Ventures | Series A |
| Eisai Innovation | Series A |
| VI Partners | Series A, Seed |
| Fyrfly Venture Partners | Series A, Seed |
| b2venture | Series A |
| Alpana Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2025
Michael Zuendel joins the Clinical and Scientific Advisory Board.
- Oct 8, 2025
Bryan J. Hansen, PhD, joins the Clinical and Scientific Advisory Board.
Altoida, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Altoida, Inc.'s valuation, stock price, and market status.
Is Altoida, Inc. a public or private company?
Altoida, Inc. is a private company.
What is the current stock price of Altoida, Inc.?
Altoida, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Altoida, Inc. worth (valuation)?
Valuation information for Altoida, Inc. is not publicly available.
Can I buy Altoida, Inc. stock?
Altoida, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Altoida, Inc.'s last funding round?
Altoida, Inc.'s most recent funding round was Series A Extension on March 30, 2022.
Who are the main investors in Altoida, Inc.?
Key investors in Altoida, Inc. include M Ventures, Eisai Innovation, Whitecap Venture Partners.
Will Altoida, Inc. IPO soon?
No public IPO plans have been announced for Altoida, Inc..
How can I track Altoida, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Altoida, Inc.'s secondary market activity and sign up for updates.